Toll样受体4在心血管疾病中的作用

被引：5

作者：

贾赫

李碧澄

田野

机构：

[1] 哈尔滨医科大学附属第一医院心血管内科

来源：

国际心血管病杂志 | 2017年 / 44卷 / 03期

关键词：

心肌组织; 炎症反应; Toll样受体4; 心血管疾病;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病];

学科分类号：

1002 ; 100201 ;

摘要：

Toll样受体4(TLR4)是最早发现的TLRs家族成员,可介导心肌组织炎症反应,参与心肌炎、心肌梗死、缺血再灌注损伤、心力衰竭等病理生理过程。该文介绍TLR4在心血管疾病中的作用。

引用

页码：143 / 145

页数：3

共 14 条

[1]

κ阿片受体激动剂通过调控Toll样受体4/核因子-κB信号通路保护大鼠缺血再灌注心肌[J]. 蔡文科,张燕,李吉国,王健.中华心血管病杂志. 2014 (10)

[2]

Toll样受体2和4在大鼠心肌缺血/再灌注损伤模型中的动态表达[J]. 刘千萍,潘坤颖,周欣,于海龙,韩国亮,李玉明,姜铁民,张梅.中国应用生理学杂志. 2013(04)

[3]

Inflammation in cardiac injury, repair and regeneration[J] . Nikolaos G. Frangogiannis.Current Opinion in Cardiology . 2015 (3)

[4] Astragaloside IV Attenuates Injury Caused by Myocardial Ischemia/Reperfusion in Rats via Regulation of Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway [J].

Lu, Meili ;

Tang, Futian ;

Zhang, Jing ;

Luan, Aina ;

Mei, Meng ;

Xu, Chonghua ;

Zhang, Suping ;

Wang, Hongxin ;

Maslov, Leonid N. .

PHYTOTHERAPY RESEARCH, 2015, 29 (04) :599-606

[5]

Regulation and actions of activin A and follistatin in myocardial ischaemia–reperfusion injury[J] . Yi Chen,Christine Rothnie,Denise Spring,Edward Verrier,Kylie Venardos,David Kaye,David J. Phillips,Mark P. Hedger,Julian A. Smith.Cytokine . 2014 (2)

[6]

Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction[J] . Hamid Soraya,Alexander S. Clanachan,Maryam Rameshrad,Nasrin Maleki-Dizaji,Mahmoud Ghazi-Khansari,Alireza Garjani.European Journal of Pharmacology . 2014

[7] S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4 [J].

Rohde, David ;

Schoen, Christoph ;

Boerries, Melanie ;

Didrihsone, Ieva ;

Ritterhoff, Julia ;

Kubatzky, Katharina F. ;

Voelkers, Mirko ;

Herzog, Nicole ;

Maehler, Mona ;

Tsoporis, James N. ;

Parker, Thomas G. ;

Linke, Bjoern ;

Giannitsis, Evangelos ;

Gao, Erhe ;

Peppel, Karsten ;

Katus, Hugo A. ;

Most, Patrick .

EMBO MOLECULAR MEDICINE, 2014, 6 (06) :778-794

[8]

S100A8 and S100A9: DAMPs at the Crossroads between Innate Immunity, Traditional Risk Factors, and Cardiovascular Disease[J] . Alexandru Schiopu,Ovidiu S. Cotoi,Stefan Frantz.Mediators of Inflammation . 2013

[9] Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury [J].